Carla Snoeck is New Ventures Lead at VIB, Belgium’s leading life sciences research institute, where she drives the creation, launch and early governance of new biotech companies based on breakthrough academic science.She works closely with scientific founders, entrepreneurs, investors and industry partners to shape investable therapeutic ventures, build strong founding teams and guide companies through formation, financing and board-level decision-making. 

Carla has played a leading role in the creation of Confo Therapeutics, Dualyx, Animab and Tanai Therapeutics, and has served, or currently serves, on the boards of several VIB spinoffs. Previously, Carla was IP Manager at Innogenetics (Fujirebio), and later at VIB, where she developed IP strategies to protect and position innovations as strong foundations for new biotech ventures. She holds an MSc in Bioscience Engineering and a PhD in Applied Biological Sciences from KU Leuven, Belgium, in collaboration with the National Autonomous University of Mexico (UNAM).